Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study

Antonia Carla Testa, Ben Van Calster, Kirsten Van Hoorde, Lil Valentin, Daniela Fischerova, Caroline Van Holsbeke, Luca Savelli, Dorella Franchi, Elisabeth Epstein, Jeroen Kaijser, Vanya Van Belle, Artur Czekierdowski, Stefano Guerriero, Robert Fruscio, Chiara Lanzani, Felice Scala, Tom Bourne, Dirk Timmerman

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

To develop a risk prediction model to preoperatively discriminate between benign, borderline, stage I invasive, stage II-IV invasive, and secondary metastatic ovarian tumours.
Original languageEnglish
Pages (from-to)g5920-g5920
JournalBMJ BRITISH MEDICAL JOURNAL
Volume349
DOIs
Publication statusPublished - 2014

Keywords

  • Adnexal Diseases
  • Adult
  • Female
  • Humans
  • Models, Statistical
  • Neoplasm Staging
  • Ovarian Neoplasms
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Assessment

Fingerprint

Dive into the research topics of 'Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study'. Together they form a unique fingerprint.

Cite this